Literature DB >> 33526066

Determinants and prevalence of relapse among patients with substance use disorders: case of Icyizere Psychotherapeutic Centre.

Eric Kabisa1,2, Emmanuel Biracyaza3,4, Jean d'Amour Habagusenga3, Aline Umubyeyi5.   

Abstract

BACKGROUND: Relapse to substance use after successful detoxication and rehabilitation is a public health concern worldwide. Forty to sixty percent of persons in general relapsed after completing detoxication and rehabilitation treatments. Although substance use remains a burden in Rwanda, very little is known about relapse among people with substance use disorder (SUD). Hence, this study aimed to examine prevalence and the factors associated with relapse to substance use at Icyizere Psychotherapeutic Centre (IPC), Rwanda.
METHODS: Retrospective, cross-sectional survey was conducted among 391 patients with SUD at IPC. Multiple logistic regression models using STATA version 13 were used to determine the factors associated with relapse among the patients with SUD.
RESULTS: Majority (84.1 %) of the participants were males. More than half (54.1 %) of them were aged between 18 and 30 years with the age average of 33 years (SD = 11.9 years). The results showed a higher prevalence of relapse among patients with SUD (59.9 %). The multivariate analyses indicated that people with SUD living only with their mothers had a greater risk of relapse compared to those with both biological parents [OR = 1.9, 95 % CI (1.02-3.6), p = 0.04]. Patients that were hospitalized between one to three months were more likely (11.2 times) to relapse after treatments compared to those who spent more than three months in hospitalization [OR = 9.2, 95 % CI (1.1-77.6), p = 0.02]. Furthermore, people that used more than two substances had 1.5 greater risk to relapse than those who consumed one substance. Participants were more likely to relapse if they lived with their peers [OR = 2.4, 95 % CI: (1.2-7.8), p = 0.01] or if they lived in a family with conflicts [OR = 2.1, 95 % CI (1.05-9.7), p = 0.02].
CONCLUSIONS: This study is conducted at one institution caring for patients with SUD. The prevalence was 59.9 %. Future studies are recommended to investigate the effectiveness of the existing relapse prevention programs in order to adjust prevention strategies.

Entities:  

Keywords:  Detoxification‐rehabilitation; Rehabilitation centre; Relapse; Substance use disorder

Year:  2021        PMID: 33526066      PMCID: PMC7851925          DOI: 10.1186/s13011-021-00347-0

Source DB:  PubMed          Journal:  Subst Abuse Treat Prev Policy        ISSN: 1747-597X


  18 in total

1.  World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects.

Authors: 
Journal:  Bull World Health Organ       Date:  2003-07-02       Impact factor: 9.408

Review 2.  Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse.

Authors:  Julie A Kauer
Journal:  Annu Rev Physiol       Date:  2004       Impact factor: 19.318

3.  Substance abuse relapse and factors associated with relapse in an inner-city sample of patients with dual diagnoses.

Authors:  Angela L Rollins; Sheila J O'Neill; Kristin E Davis; Timothy S Devitt
Journal:  Psychiatr Serv       Date:  2005-10       Impact factor: 3.084

Review 4.  Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review.

Authors:  Clara M Bradizza; Paul R Stasiewicz; Nicole D Paas
Journal:  Clin Psychol Rev       Date:  2006-01-06

Review 5.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

Authors:  Harvey A Whiteford; Louisa Degenhardt; Jürgen Rehm; Amanda J Baxter; Alize J Ferrari; Holly E Erskine; Fiona J Charlson; Rosana E Norman; Abraham D Flaxman; Nicole Johns; Roy Burstein; Christopher J L Murray; Theo Vos
Journal:  Lancet       Date:  2013-08-29       Impact factor: 79.321

6.  Factors associated with relapse in patients with schizophrenia.

Authors:  Luis San; Miquel Bernardo; Agustín Gómez; Mario Peña
Journal:  Int J Psychiatry Clin Pract       Date:  2012-06-26       Impact factor: 1.812

Review 7.  DSM-5 criteria for substance use disorders: recommendations and rationale.

Authors:  Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2013-08       Impact factor: 18.112

8.  The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Psychiatry       Date:  2018-11-01       Impact factor: 27.083

9.  Prevalence of psychoactive substance use among youth in Rwanda.

Authors:  Maurice Kanyoni; Darius Gishoma; Vedaste Ndahindwa
Journal:  BMC Res Notes       Date:  2015-05-08

Review 10.  Relapse prevention.

Authors:  Jayakrishnan Menon; Arun Kandasamy
Journal:  Indian J Psychiatry       Date:  2018-02       Impact factor: 1.759

View more
  1 in total

1.  Predictors of Workplace Substance Reuse among Patients with Alcohol or Illegal Substance Use Disorder in the Workplace.

Authors:  Su-Ting Hsu; Hung-Chi Wu; Hui-Tzu Chien; Dian-Jeng Li
Journal:  Int J Environ Res Public Health       Date:  2022-08-14       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.